In terms of diagnosis and recurrence monitoring, miRNA demonstrates higher specificity (93.4%) and sensitivity (88.7%) compared to AFP, regardless of the histopathological type, patient age, or anatomical location of the tumor [57,67,68]. Here, AFP is linked to neoplasm.